참고문헌
- Abu-Remaileh M, Wyant GA, Kim C, Laqtom NN, Abbasi M, Chan SH, et al. : Lysosomal metabolomics reveals V-ATPase- and mTOR-dependent regulation of amino acid efflux from lysosomes. Science 358 : 807-813, 2017 https://doi.org/10.1126/science.aan6298
- Alcantara D, Timms AE, Gripp K, Baker L, Park K, Collins S, et al. : Mutations of AKT3 are associated with a wide spectrum of developmental disorders including extreme megalencephaly. Brain 140 : 2610-2622, 2017 https://doi.org/10.1093/brain/awx203
- Alfaiz AA, Micale L, Mandriani B, Augello B, Pellico MT, Chrast J, et al. : TBC1D7 mutations are associated with intellectual disability, macrocrania, patellar dislocation, and celiac disease. Hum Mutat 35 : 447-451, 2014 https://doi.org/10.1002/humu.22529
- Aronica E, Becker AJ, Spreafico R : Malformations of cortical development. Brain Pathol 22 : 380-401, 2012 https://doi.org/10.1111/j.1750-3639.2012.00581.x
- Avoli M, Bernasconi A, Mattia D, Olivier A, Hwa GG : Epileptiform discharges in the human dysplastic neocortex: in vitro physiology and pharmacology. Ann Neurol 46 : 816-826, 1999 https://doi.org/10.1002/1531-8249(199912)46:6<816::AID-ANA3>3.0.CO;2-O
- Backman SA, Stambolic V, Suzuki A, Haight J, Elia A, Pretorius J, et al. : Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat Genet 29 : 396-403, 2001 https://doi.org/10.1038/ng782
- Baek ST, Copeland B, Yun EJ, Kwon SK, Guemez-Gamboa A, Schaffer AE, et al. : An AKT3-FOXG1-reelin network underlies defective migration in human focal malformations of cortical development. Nat Med 21 : 1445-1454, 2015 https://doi.org/10.1038/nm.3982
- Banko JL, Poulin F, Hou L, DeMaria CT, Sonenberg N, Klann E : The translation repressor 4E-BP2 is critical for eIF4F complex formation, synaptic plasticity, and memory in the hippocampus. J Neurosci 25 : 9581-9590, 2005 https://doi.org/10.1523/JNEUROSCI.2423-05.2005
- Baple EL, Maroofian R, Chioza BA, Izadi M, Cross HE, Al-Turki S, et al. : Mutations in KPTN cause macrocephaly, neurodevelopmental delay, and seizures. Am J Hum Genet 94 : 87-94, 2014 https://doi.org/10.1016/j.ajhg.2013.10.001
- Bar-Peled L, Schweitzer LD, Zoncu R, Sabatini DM : Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1. Cell 150 : 1196-1208, 2012 https://doi.org/10.1016/j.cell.2012.07.032
- Basel-Vanagaite L, Hershkovitz T, Heyman E, Raspall-Chaure M, Kakar N, Smirin-Yosef P, et al. : Biallelic SZT2 mutations cause infantile encephalopathy with epilepsy and dysmorphic corpus callosum. Am J Hum Genet 93 : 524-529, 2013 https://doi.org/10.1016/j.ajhg.2013.07.005
- Bast T, Ramantani G, Seitz A, Rating D : Focal cortical dysplasia: prevalence, clinical presentation and epilepsy in children and adults. Acta Neurol Scand 113 : 72-81, 2006 https://doi.org/10.1111/j.1600-0404.2005.00555.x
- Baulac S : MTOR signaling pathway genes in focal epilepsies in Rossignol E, Carmant L, Lacaille JC (eds) : Progress in Brain Research. Amsterdam : Elsevier, 2016, Vol 226, pp61-79
- Baulac S, Ishida S, Marsan E, Miquel C, Biraben A, Nguyen DK, et al. : Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations. Ann Neurol 77 : 675-683, 2015 https://doi.org/10.1002/ana.24368
- Baybis M, Yu J, Lee A, Golden JA, Weiner H, McKhann G 2nd, et al. : mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 56 : 478-487, 2004 https://doi.org/10.1002/ana.20211
- Beaumont V, Zhong N, Fletcher R, Froemke RC, Zucker RS : Phosphorylation and local presynaptic protein synthesis in calcium- and calcineurindependent induction of crayfish long-term facilitation. Neuron 32 : 489-501, 2001 https://doi.org/10.1016/S0896-6273(01)00483-4
- Ben-Sahra I, Howell JJ, Asara JM, Manning BD : Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science 339 : 1323-1328, 2013 https://doi.org/10.1126/science.1228792
- Bercury KK, Dai J, Sachs HH, Ahrendsen JT, Wood TL, Macklin WB : Conditional ablation of raptor or rictor has differential impact on oligodendrocyte differentiation and CNS myelination. J Neurosci 34 : 4466-4480, 2014 https://doi.org/10.1523/JNEUROSCI.4314-13.2014
- Bishop KM : Progress and promise of antisense oligonucleotide therapeutics for central nervous system diseases. Neuropharmacology 120 : 56-62, 2017 https://doi.org/10.1016/j.neuropharm.2016.12.015
- Blumcke I : Neuropathology of focal epilepsies: a critical review. Epilepsy Behav 15 : 34-39, 2009 https://doi.org/10.1016/j.yebeh.2009.02.033
- Brown EJ, Beal PA, Keith CT, Chen J, Shin TB, Schreiber SL : Control of p70 S6 kinase by kinase activity of FRAP in vivo. Nature 377 : 441-446, 1995 https://doi.org/10.1038/377441a0
- Capo-Chichi JM, Tcherkezian J, Hamdan FF, Decarie JC, Dobrzeniecka S, Patry L, et al. : Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly. J Med Genet 50 : 740-744, 2013 https://doi.org/10.1136/jmedgenet-2013-101680
- Cardamone M, Flanagan D, Mowat D, Kennedy SE, Chopra M, Lawson JA : Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex. J Pediatr 164 : 1195-1200, 2014 https://doi.org/10.1016/j.jpeds.2013.12.053
- Carvill GL, Crompton DE, Regan BM, McMahon JM, Saykally J, Zemel M, et al. : Epileptic spasms are a feature of DEPDC5 mTORopathy. Neurol Genet 1 : e17, 2015 https://doi.org/10.1212/NXG.0000000000000016
- Casadio A, Martin KC, Giustetto M, Zhu H, Chen M, Bartsch D, et al. : A transient, neuron-wide form of creb-mediated long-term facilitation can be stabilized at specific synapses by local protein synthesis. Cell 99 : 221-237, 1999 https://doi.org/10.1016/S0092-8674(00)81653-0
- Cen Z, Guo Y, Lou Y, Jiang B, Wang J, Feng J : De novo mutation in DEPDC5 associated with unilateral pachygyria and intractable epilepsy. Seizure 50 : 1-3, 2017 https://doi.org/10.1016/j.seizure.2017.03.014
- Cepeda C, Levinson S, Yazon VW, Barry J, Mathern GW, Fallah A, et al. : Cellular antiseizure mechanisms of everolimus in pediatric tuberous sclerosis complex, cortical dysplasia, and non-mTOR-mediated etiologies. Epilepsia Open 3(Suppl Suppl 2) : 180-190, 2018
- Chen HH, Chen C, Hung SC, Liang SY, Lin SC, Hsu TR, et al. : Cognitive and epilepsy outcomes after epilepsy surgery caused by focal cortical dysplasia in children: early intervention maybe better. Child's Nerv Syst 30 : 1885-1895, 2014 https://doi.org/10.1007/s00381-014-2463-y
- Cheung KM, Lam CW, Chan YK, Siu WK, Yong L : Atypical focal cortical dysplasia in a patient with Cowden syndrome. Hong Kong Med J 20 : 165-167, 2014
- Child ND, Cascino GD : Mystery case: Cowden syndrome presenting with partial epilepsy related to focal cortical dysplasia. Neurology 81 : e98-e99, 2013 https://doi.org/10.1212/WNL.0b013e3182a55ef0
- Citraro R, Leo A, Constanti A, Russo E, De Sarro G : mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis. Pharmacol Res 107 : 333-343, 2016 https://doi.org/10.1016/j.phrs.2016.03.039
- Crino PB : Focal brain malformations: a spectrum of disorders along the mTOR cascade. Novartis Found Smyp 288 : 260-272; discussion 272-281, 2007
- Crino PB : The mTOR signalling cascade: paving new roads to cure neurological disease. Nat Rev Neurol 12 : 379-392, 2016 https://doi.org/10.1038/nrneurol.2016.81
- Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P : mTOR controls mitochondrial oxidative function through a YY1-PGC-1a transcriptional complex. Nature 450 : 736-740, 2007 https://doi.org/10.1038/nature06322
- Curatolo P, Franz DN, Lawson JA, Yapici Z, Ikeda H, Polster T, et al. : Adjunctive everolimus for children and adolescents with treatmentrefractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial. Lancet Child Adolesc Health 2 : 495-504, 2018 https://doi.org/10.1016/S2352-4642(18)30099-3
- D'Gama AM, Geng Y, Couto JA, Martin B, Boyle EA, LaCoursiere CM, et al. : Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia. Ann Neurol 77 : 720-725, 2015 https://doi.org/10.1002/ana.24357
- De Benedetti A, Joshi-Barve S, Rinker-Schaeffer C, Rhoads RE : Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF-4E and the p220 component of eIF-4F. Mol Cell Biol 11 : 5435-5445, 1991 https://doi.org/10.1128/MCB.11.11.5435
- Dibble CC, Elis W, Menon S, Qin W, Klekota J, Asara JM, et al. : TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol Cell 47 : 535-546, 2012 https://doi.org/10.1016/j.molcel.2012.06.009
-
Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M : S6K1- and
${\beta}TRCP$ -mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314 : 467-471, 2006 https://doi.org/10.1126/science.1130276 - Dutchak PA, Laxman S, Estill SJ, Wang C, Wang Y, Wang Y, et al. : Regulation of hematopoiesis and methionine homeostasis by mTORC1 inhibitor NPRL2. Cell Rep 12 : 371-379, 2015 https://doi.org/10.1016/j.celrep.2015.06.042
- Ehninger D, Han S, Shilyansky C, Zhou Y, Li W, Kwiatkowski DJ, et al. : Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med 14 : 843-848, 2008 https://doi.org/10.1038/nm1788
- Eisen T, Sternberg CN, Robert C, Mulders P, Pyle L, Zbinden S, et al. : Targeted therapies for renal cell carcinoma: review of adverse event management strategies. J Natl Cancer Inst 104 : 93-113, 2012 https://doi.org/10.1093/jnci/djr511
- Eng CP, Sehgal SN, Vezina C : Activity of rapamycin (AY-22,989) against transplanted tumors. J Antibiot (Tokyo) 37 : 1231-1237, 1984 https://doi.org/10.7164/antibiotics.37.1231
- European Chromosome 16 Tuberous Sclerosis Consortium : Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75 : 1305-15, 1993 https://doi.org/10.1016/0092-8674(93)90618-Z
- Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, et al. : Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med 337 : 1723-1732, 2017
- Frankel WN, Yang Y, Mahaffey CL, Beyer BJ, O'Brien TP : Szt2, a novel gene for seizure threshold in mice. Genes Brain Behav 8 : 568-576, 2009 https://doi.org/10.1111/j.1601-183X.2009.00509.x
- Franz DN, Agricola K, Mays M, Tudor C, Care MM, Holland-Bouley K, et al. : Everolimus for subependymal giant cell astrocytoma: 5-year final analysis. Ann Neurol 78 : 929-938, 2015 https://doi.org/10.1002/ana.24523
- Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, et al. : Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study. Lancet Oncol 15 : 1513-1520, 2014 https://doi.org/10.1016/S1470-2045(14)70489-9
- French JA, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, et al. : Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet 388 : 2153-2163, 2016 https://doi.org/10.1016/S0140-6736(16)31419-2
- Gingras A, Kennedy SG, O'Leary MA, Sonenberg N, Hay N : 4E-BP1, a repressor of mRNA translation, is phosphorylated by the Akt(PKB) signaling pathway. Genes Dev 12 : 502-513, 1998 https://doi.org/10.1101/gad.12.4.502
- Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, et al. : Regulation of 4E-BP1 phosphorylation : a novel two-step mechanism. Genes Dev 13 : 1422-1437, 1999 https://doi.org/10.1101/gad.13.11.1422
- Gingras AC, Raught B, Sonenberg N : eIF4 initiation factors : effectors of mRNA recruitment of translation. Annu Rev Biochem 68 : 913-963, 1999 https://doi.org/10.1146/annurev.biochem.68.1.913
-
Gong X, Zhang L, Huang T, Lin T V., Miyares L, Wen J, et al. : Activating the translational repressor 4E-BP or reducing
$S6K-GSK3{\beta}$ activity prevents accelerated axon growth induced by hyperactive mTOR in vivo. Hum Mol Genet 24 : 5746-5758, 2015 https://doi.org/10.1093/hmg/ddv295 - Gordo G, Tenorio J, Arias P, Santos-Simarro F, Garcia-Minaur S, Moreno JC, et al. : mTOR mutations in Smith-Kingsmore syndrome: four additional patients and a review. Clin Genet 93 : 762-775, 2018 https://doi.org/10.1111/cge.13135
- Gu X, Orozco JM, Saxton RA, Condon KJ, Liu GY, Krawczyk PA, et al. : SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway. Science 358 : 813-818, 2017 https://doi.org/10.1126/science.aao3265
- Hadamitzky M, Herring A, Kirchhof J, Bendix I, Haight MJ, Keyvani K, et al. : Repeated systemic treatment with rapamycin affects behavior and amygdala protein expression in rats. Int J Neuropsychopharmacol 21 : 592-602, 2018 https://doi.org/10.1093/ijnp/pyy017
- Han JM, Jeong SJ, Park MC, Kim G, Kwon NH, Kim HK, et al. : LeucyltRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 149 : 410-424, 2012 https://doi.org/10.1016/j.cell.2012.02.044
- Heitman J, Movva NR, Hall MN : Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253 : 905-909, 1991 https://doi.org/10.1126/science.1715094
- Hentges K, Thompson K, Peterson A : The flat-top gene is required for the expansion and regionalization of the telencephalic primordium. Development 126 : 1601-9, 1999 https://doi.org/10.1242/dev.126.8.1601
- Hiremath LS, Webb NR, Rhoads RE : Immunological detection of the messenger RNA cap-binding protein. J Biol Chem 260 : 7843-7849, 1985 https://doi.org/10.1016/S0021-9258(17)39529-7
- Holz MK, Ballif BA, Gygi SP, Blenis J : mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123 : 569-580, 2005 https://doi.org/10.1016/j.cell.2005.10.024
- Hou L, Klann E : Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J Neurosci 24 : 6352-6361, 2004 https://doi.org/10.1523/JNEUROSCI.0995-04.2004
- Hsieh LS, Wen JH, Claycomb K, Huang Y, Harrsch FA, Naegele JR, et al. : Convulsive seizures from experimental focal cortical dysplasia occur in dependently of cell misplacement. Nat Commun 7 : 11753, 2016 https://doi.org/10.1038/ncomms11753
- Huber KM, Kayser MS, Bear MF : Role for rapid dendritic protein synthesis in hippocampal depression. Science 288 : 1254-1257, 2000 https://doi.org/10.1126/science.288.5469.1254
- Hughes J, Dawson R, Tea M, McAninch D, Piltz S, Jackson D, et al. : Knockout of the epilepsy gene Depdc5 in mice causes severe embryonic dysmorphology with hyperactivity of mTORC1 signalling. Sci Rep 7 : 12618, 2017 https://doi.org/10.1038/s41598-017-12574-2
- Iffland PH 2nd, Crino PB : Focal cortical dysplasia: gene mutations, cell signaling, and therapeutic implications. Annu Rev Pathol 12 : 547-571, 2017 https://doi.org/10.1146/annurev-pathol-052016-100138
- Inoki K, Li Y, Xu T, Guan KL : Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17 : 1829-1834, 2003 https://doi.org/10.1101/gad.1110003
- Jansen LA, Mirzaa GM, Ishak GE, O'Roak BJ, Hiatt JB, Roden WH, et al. : PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia. Brain 138(Pt 6) : 1613-1628, 2015 https://doi.org/10.1093/brain/awv045
- Jung J, Genau HM, Behrends C : Amino acid-dependent mTORC1 regulation by the lysosomal membrane protein SLC38A9. Mol Cell Biol 35 : 2479-2494, 2015 https://doi.org/10.1128/MCB.00125-15
- Keppler-Noreuil KM, Parker VE, Darling TN, Martinez-Agosto JA : Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies. Am J Med Genet C Semin Med Genet 172 : 402-421, 2016 https://doi.org/10.1002/ajmg.c.31531
- Klawitter J, Gottschalk S, Hainz C, Leibfritz D, Christians U, Serkova NJ : Immunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolism. Chem Res Toxicol 23 : 608-619, 2010 https://doi.org/10.1021/tx900351q
- Kowalczyk MS, Hughes JR, Babbs C, Sanchez-Pulido L, Szumska D, Sharpe JA, et al. : Nprl3 is required for normal development of the cardiovascular system. Mamm Genome 23 : 404-415, 2012 https://doi.org/10.1007/s00335-012-9398-y
- Krueger DA, Care MM, Agricola K, Tudor C, Mays M, Franz DN : Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma. Neurology 80 : 574-580, 2013 https://doi.org/10.1212/WNL.0b013e3182815428
- Krueger DA, Care MM, Holland K, Agricola K, Tudor C, Mangeshkar P, et al. : Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 369 : 1801-1811, 2010
- Krueger DA, Wilfong AA, Mays M, Talley CM, Agricola K, Tudor C, et al. : Long-term treatment of epilepsy with everolimus in tuberous sclerosis. Neurology 87 : 2408-2415, 2016 https://doi.org/10.1212/WNL.0000000000003400
- Kuegler PB, Zimmer B, Waldmann T, Baudis B, Ilmjarv S, Hescheler J, et al. : Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. ALTEX 27 : 17-42, 2010
- Kumar V, Zhang MX, Swank MW, Kunz J, Wu G : Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J Neurosci 25 : 11288-11299, 2005 https://doi.org/10.1523/JNEUROSCI.2284-05.2005
- Kwon CH, Zhu X, Zhang J, Knoop LL, Tharp R, Smeyne RJ, et al. : Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat Genet 29 : 404-411, 2001 https://doi.org/10.1038/ng781
- Lee JH, Huynh M, Silhavy JL, Kim S, Dixon-Salazar T, Heiberg A, et al. : De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 44 : 941-945, 2012 https://doi.org/10.1038/ng.2329
- Lee SK, Kim DW : Focal cortical dysplasia and epilepsy surgery. J Epilepsy Res 3 : 43-47, 2013 https://doi.org/10.14581/jer.13009
- Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, et al. : mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329 : 959-964, 2010 https://doi.org/10.1126/science.1190287
- Lim JS, Gopalappa R, Kim SH, Ramakrishna S, Lee M, Kim WI, et al. : Somatic mutations in TSC1 and TSC2 cause focal cortical dysplasia. Am J Hum Genet 100 : 454-472, 2017 https://doi.org/10.1016/j.ajhg.2017.01.030
- Lim JS, Kim WI, Kang HC, Kim SH, Park AH, Park EK, et al. : Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat Med 21 : 395-400, 2015 https://doi.org/10.1038/nm.3824
- Lin TV, Hsieh L, Kimura T, Malone TJ, Bordey A : Normalizing translation through 4E-BP prevents mTOR-driven cortical mislamination and ameliorates aberrant neuron integration. Proc Natl Acad Sci U S A 113 : 11330-11335, 2016 https://doi.org/10.1073/pnas.1605740113
- Lipton JO, Sahin M : The neurology of mTOR. Neuron 84 : 275-291, 2014 https://doi.org/10.1016/j.neuron.2014.09.034
- Ljungberg MC, Bhattacharjee MB, Lu Y, Armstrong DL, Yoshor D, Swann JW, et al. : Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia. Ann Neurol 60 : 420-429, 2006 https://doi.org/10.1002/ana.20949
- Ljungberg MC, Sunnen CN, Lugo JN, Anderson AE, D'Arcangelo G : Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia. Dis Model Mech 2 : 389-398, 2009 https://doi.org/10.1242/dmm.002386
- Long X, Lin Y, Ortiz-Vega S, Yonezawa K, Avruch J : Rheb binds and regulates the mTOR kinase. Curr Biol 15 : 702-713, 2005 https://doi.org/10.1016/j.cub.2005.02.053
- Luikart BW, Schnell E, Washburn EK, Bensen AL, Tovar KR, Westbrook GL : Pten knockdown in vivo increases excitatory drive onto dentate granule cells. J Neurosci 31 : 4345-4354, 2011 https://doi.org/10.1523/JNEUROSCI.0061-11.2011
- Marchese M, Conti V, Valvo G, Moro F, Muratori F, Tancredi R, et al. : Autism-epilepsy phenotype with macrocephaly suggests PTEN, but not GLIALCAM, genetic screening. BMC Med Genet 15 : 26, 2014 https://doi.org/10.1186/1471-2350-15-26
- Marsan E, Baulac S : Review: mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy. Neuropathol Appl Neurobiol 44 : 6-17, 2018 https://doi.org/10.1111/nan.12463
- Marsan E, Ishida S, Schramm A, Weckhuysen S, Muraca G, Lecas S, et al. : Depdc5 knockout rat: a novel model of mTORopathy. Neurobiol Dis 89 : 180-189, 2016 https://doi.org/10.1016/j.nbd.2016.02.010
- Martel RR, Klicius J, Galet S : Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can J Physiol Pharmacol 55 : 48-51, 1977 https://doi.org/10.1139/y77-007
- Martinez-Lizana E, Fauser S, Brandt A, Schuler E, Wiegand G, Doostkam S, et al. : Long-term seizure outcome in pediatric patients with focal cortical dysplasia undergoing tailored and standard surgical resections. Seizure 62 : 66-73, 2018 https://doi.org/10.1016/j.seizure.2018.09.021
- Mc Cormack A, Sharpe C, Gregersen N, Smith W, Hayes I, George AM, et al. : 12q14 microdeletions: additional case series with confirmation of a macrocephaly region. Case Rep Genet 2015 : 192071, 2015
- Meikle L, Talos DM, Onda H, Pollizzi K, Rotenberg A, Sahin M, et al. : A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J Neurosci 27 : 5546-5558, 2007 https://doi.org/10.1523/JNEUROSCI.5540-06.2007
- Mester J, Eng C : When overgrowth bumps into cancer: the PTEN-opathies. Am J Med Genet C Semin Med Genet 163C : 114-121, 2013 https://doi.org/10.1002/ajmg.c.31364
- Millichap J : Cowden syndrome with cortical malformation and epilepsy. Pediatr Neurol Briefs 34 : 7, 2013
- Mirzaa GM, Conway RL, Gripp KW, Lerman-Sagie T, Siegel DH, deVries LS, et al. : Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis. Am J Med Genet A 158A : 269-291, 2012 https://doi.org/10.1002/ajmg.a.34402
- Miyata H, Chiang AC, Vinters HV : Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis. Ann Neurol 56 : 510-9, 2004 https://doi.org/10.1002/ana.20234
- Moosa S, Bohrer-Rabel H, Altmuller J, Beleggia F, Nurnberg P, Li Y, et al. : Smith-Kingsmore syndrome: a third family with the MTOR mutation c.5395G>A p.(Glu1799Lys) and evidence for paternal gonadal mosaicism. Am J Med Genet A 173 : 264-267, 2017 https://doi.org/10.1002/ajmg.a.37999
- Mroske C, Rasmussen K, Shinde DN, Huether R, Powis Z, Lu HM, et al. : Germline activating MTOR mutation arising through gonadal mosaicism in two brothers with megalencephaly and neurodevelopmental abnormalities. BMC Med Genet 16 : 102, 2015
- Muncy J, Butler IJ, Koenig KM : Rapamycin reduces seizure frequency in tuberous sclerosis complex. J Child Neurol 24 : 477, 2009 https://doi.org/10.1177/0883073808324535
- Nellist M, Schot R, Hoogeveen-Westerveld M, Neuteboom RF, van der Louw EJ, Lequin MH, et al. : Germline activating AKT3 mutation associated with megalencephaly, polymicrogyria, epilepsy and hypoglycemia. Mol Genet Metab 114 : 467-473, 2015 https://doi.org/10.1016/j.ymgme.2014.11.018
- Oh WJ, Jacinto E : mTOR complex 2 signaling and functions. Cell Cycle 10 : 2305-2316, 2011 https://doi.org/10.4161/cc.10.14.16586
- Orloff MS, He X, Peterson C, Chen F, Chen JL, Mester JL, et al. : Germline PIK3CA and AKT1 mutations in cowden and cowden-like syndromes. Am J Hum Genet 92 : 76-80, 2013 https://doi.org/10.1016/j.ajhg.2012.10.021
- Orlova KA, Parker WE, Heuer GG, Tsai V, Yoon J, Baybis M, et al. : STRADa deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice. J Clin Invest 120 : 1591-1602, 2010 https://doi.org/10.1172/JCI41592
- Pajusalu S, Reimand T, Ounap K : Novel homozygous mutation in KPTN gene causing a familial intellectual disability-macrocephaly syndrome. Am J Med Genet A 167A : 1913-1915, 2015 https://doi.org/10.1002/ajmg.a.37105
- Pallet N, Legendre C : Adverse events associated with mTOR inhibitors. Expert Opin Drug Saf 12 : 177-186, 2013 https://doi.org/10.1517/14740338.2013.752814
- Park SM, Lim JS, Ramakrishina S, Kim SH, Kim WK, Lee J, et al. : Brain somatic mutations in MTOR disrupt neuronal ciliogenesis, leading to focal cortical dyslamination. Neuron 99 : 83-97.e7, 2018 https://doi.org/10.1016/j.neuron.2018.05.039
- Parker WE, Orlova KA, Parker WH, Birnbaum JF, Krymskaya VP, Goncharov DA, et al. : Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder. Sci Transl Med 5 : 182ra53, 2013 https://doi.org/10.1126/scitranslmed.3005271
- Peters JM, Taquet M, Prohl AK, Scherrer B, van Eeghen AM, Prabhu SP, et al. : Diffusion tensor imaging and related techniques in tuberous sclerosis complex: review and future directions. Future Neurol 8 : 583-597, 2013 https://doi.org/10.2217/fnl.13.37
- Pilarski R : Cowden syndrome: a critical review of the clinical literature. J Genet Couns 18 : 13-27, 2009 https://doi.org/10.1007/s10897-008-9187-7
- Pitkanen A, Lukasiuk K : Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 10 : 173-186, 2011 https://doi.org/10.1016/S1474-4422(10)70310-0
- Poduri A, Evrony GD, Cai X, Elhosary PC, Beroukhim R, Lehtinen MK, et al. : Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron 74 : 41-48, 2012 https://doi.org/10.1016/j.neuron.2012.03.010
- Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, Leevers S, et al. : SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 8 : 224-236, 2008 https://doi.org/10.1016/j.cmet.2008.07.007
- Raab-Graham KF, Haddick PC, Jan YN, Jan LY : Activity- and mTORdependent suppression of Kv1.1 channel mRNA translation in dendrites. Science 314 : 144-148, 2006 https://doi.org/10.1126/science.1131693
- Rabanal-Ruiz Y, Otten EG, Korolchuk VI : mTORC1 as the main gateway to autophagy. Essays Biochem 61 : 565-584, 2017 https://doi.org/10.1042/EBC20170027
- Rennebeck G, Kleymenova EV, Anderson R, Yeung RS, Artzt K, Walker CL : Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Proc Natl Acad Sci U S A 95 : 15629-15634, 1998 https://doi.org/10.1073/pnas.95.26.15629
- Ribierre T, Deleuze C, Bacq A, Baldassari S, Marsan E, Chipaux M, et al. : Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia-associated epilepsy. J Clin Investig 128 : 2452-2458, 2018 https://doi.org/10.1172/JCI99384
- Ricos MG, Hodgson BL, Pippucci T, Saidin A, Ong YS, Heron SE, et al. : Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy. Ann Neurol 79 : 120-131, 2016 https://doi.org/10.1002/ana.24547
- Riviere JB, Mirzaa GM, O'Roak BJ, Beddaoui M, Alcantara D, Conway RL, et al. : De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet 44 : 934-940, 2012 https://doi.org/10.1038/ng.2331
- Roy A, Skibo J, Kalume F, Ni J, Rankin S, Lu Y, et al. : Mouse models of human PIK3CA-related brain overgrowth have acutely treatable epilepsy. Elife 4 : e12703, 2015 https://doi.org/10.7554/eLife.12703
- Sabatini DM : Twenty-five years of mTOR: uncovering the link from nutrients to growth. Proc Natl Acad Sci U S A 114 : 11818-11825, 2017 https://doi.org/10.1073/pnas.1716173114
- Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P, Snyder SH : RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78 : 35-43, 1994 https://doi.org/10.1016/0092-8674(94)90570-3
- Salinas V, Vega P, Piccirilli MV, Chicco C, Ciraolo C, Christiansen S, et al. : Identification of a somatic mutation in the RHEB gene through high depth and ultra-high depth next generation sequencing in a patient with Hemimegalencephaly and drug resistant Epilepsy. Eur J Med Genet, 2018 [Epub ahead of print]
- Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, Bar-Peled L, et al. : The rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320 : 1496-1501, 2008 https://doi.org/10.1126/science.1157535
- Sarbassov DD, Guertin DA, Ali SM, Sabatini DM : Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 : 1098-1101, 2005 https://doi.org/10.1126/science.1106148
- Sare RM, Song A, Loutaev I, Cook A, Maita I, Lemons A, et al. : Negative effects of chronic rapamycin treatment on behavior in a mouse model of fragile X syndrome. Front Mol Neurosci 10 : 452, 2018 https://doi.org/10.3389/fnmol.2017.00452
- Saxton RA, Sabatini DM : mTOR signaling in growth, metabolism, and disease. Cell 168 : 960-976, 2017 https://doi.org/10.1016/j.cell.2017.02.004
- Scerri T, Riseley JR, Gillies G, Pope K, Burgess R, Mandelstam SA, et al. : Familial cortical dysplasia type IIA caused by a germline mutation in DEPDC5. Ann Clin Transl Neurol 2 : 575-580, 2015 https://doi.org/10.1002/acn3.191
- Schick V, Majores M, Engels G, Spitoni S, Koch A, Elger CE, et al. : Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias. Acta Neuropathol 112 : 715-725, 2006 https://doi.org/10.1007/s00401-006-0128-y
- Schwartzkroin PA, Walsh CA : Cortical malformations and epilepsy. Ment Retard Dev Disabil Res Rev 6 : 268-280, 2000 https://doi.org/10.1002/1098-2779(2000)6:4<268::AID-MRDD6>3.0.CO;2-B
- Sim JC, Scerri T, Fanjul-Fernandez M, Riseley JR, Gillies G, Pope K, et al. : Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3. Ann Neurol 79 : 132-137, 2016 https://doi.org/10.1002/ana.24502
- Sonenberg N, Hinnebusch AG : Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136 : 731-745, 2009 https://doi.org/10.1016/j.cell.2009.01.042
- Southwell AL, Skotte NH, Bennett CF, Hayden MR : Antisense oligonucleotide therapeutics for inherited neurodegenerative diseases. Trends Mol Med 18 : 634-643, 2012 https://doi.org/10.1016/j.molmed.2012.09.001
- Tang G, Gudsnuk K, Kuo SH, Cotrina ML, Rosoklija G, Sosunov A, et al. : Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron 83 : 1131-1143, 2014 https://doi.org/10.1016/j.neuron.2014.07.040
- Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, Sabatini BL : Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci 8 : 1727-1734, 2005 https://doi.org/10.1038/nn1566
- Teutonico A, Schena PF, Di Paolo S : Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J Am Soc Nephrol 16 : 3128-3135, 2005 https://doi.org/10.1681/ASN.2005050487
- Tokuda S, Mahaffey CL, Monks B, Faulkner CR, Birnbaum MJ, Danzer SC, et al. : A novel Akt3 mutation associated with enhanced kinase activity and seizure susceptibility in mice. Hum Mol Genet 20 : 988-999, 2011 https://doi.org/10.1093/hmg/ddq544
- Uhlmann EJ, Wong M, Baldwin RL, Bajenaru ML, Onda H, Kwiatkowski DJ, et al. : Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann Neurol 52 : 285-296, 2002 https://doi.org/10.1002/ana.10283
- van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, et al. : Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277 : 805-808, 1997 https://doi.org/10.1126/science.277.5327.805
- Venkatesan C, Angle B, Millichap JJ : Early-life epileptic encephalopathy secondary to SZT2 pathogenic recessive variants. Epileptic Disord 18 : 195-200, 2016 https://doi.org/10.1684/epd.2016.0828
- Vezina C, Kudelski A, Sehgal SN : Rapamycin (AY-22,989), a new antifungal antibiotic I. Taxonomy of the producing Streptomycete and isolation of the active principle. J Antibiot (Tokyo) 28 : 721-726, 1975 https://doi.org/10.7164/antibiotics.28.721
- von der Brelie C, Waltereit R, Zhang L, Beck H, Kirschstein T : Impaired synaptic plasticity in a rat model of tuberous sclerosis. Eur J Neurosci 23 : 686-692, 2006 https://doi.org/10.1111/j.1460-9568.2006.04594.x
- Wahl SE, McLane LE, Bercury KK, Macklin WB, Wood TL : Mammalian target of rapamycin promotes oligodendrocyte differentiation, initiation and extent of CNS myelination. J Neurosci 34 : 4453-4465, 2014 https://doi.org/10.1523/JNEUROSCI.4311-13.2014
- Way SW, Mckenna J 3rd, Mietzsch U, Reith RM, Wu HC, Gambello MJ : Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Hum Mol Genet 18 : 1252-1265, 2009 https://doi.org/10.1093/hmg/ddp025
- Weston MC, Chen H, Swann JW : Multiple roles for mammalian target of rapamycin signaling in both glutamatergic and GABAergic synaptic transmission. J Neurosci 32 : 11441-11452, 2012 https://doi.org/10.1523/JNEUROSCI.1283-12.2012
- Wiemer-Kruel A, Woerle H, Strobl K, Bast T : Everolimus for the treatment of subependymal giant cell astrocytoma probably causing seizure aggravation in a child with tuberous sclerosis complex: a case report. Neuropediatrics 45 : 129-131, 2014 https://doi.org/10.1055/s-0033-1360481
- Wolfson RL, Chantranupong L, Wyant GA, Gu X, Orozco JM, Shen K, et al. : KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1. Nature 543 : 438-442, 2017 https://doi.org/10.1038/nature21423
- Wyant GA, Abu-Remaileh M, Frenkel EM, Laqtom NN, Dharamdasani V, Lewis CA, et al. : Nufip1 is a ribosome receptor for starvation-induced ribophagy. Science 360 : 751-758, 2018 https://doi.org/10.1126/science.aar2663
- Xiong Q, Oviedo HV, Trotman LC, Zador AM : PTEN regulation of local and long-range connections in mouse auditory cortex. J Neurosci 32 : 1643-1652, 2012 https://doi.org/10.1523/JNEUROSCI.4480-11.2012
- Xu Q, Uliel-Sibony S, Dunham C, Sarnat H, Flores-Sarnat L, Brunga L, et al. : mTOR inhibitors as a new therapeutic strategy in treatment resistant epilepsy in hemimegalencephaly: a case report. J Child Neurol 34 : 132-138, 2019 https://doi.org/10.1177/0883073818813238
- Yeung RS, Katsetos CD, Klein-szanto A : Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis. Am J Pathol 151 : 1477-1486, 1997
- Yeung RS, Xiao GH, Jin F, Lee WC, Testa JR, Knudson AG : Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci U S A 91 : 11413-11416, 1994 https://doi.org/10.1073/pnas.91.24.11413
- Yoon BC, Zivraj KH, Holt CE : Local translation and mRNA trafficking in axon pathfinding. Results Probl Cell Differ 48 : 269-288, 2009 https://doi.org/10.1007/400_2009_5
- Zeng LH, Rensing NR, Zhang B, Gutmann DH, Gambello MJ, Wong M : Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Hum Mol Genet 20 : 445-454, 2011 https://doi.org/10.1093/hmg/ddq491
- Zeng LH, Xu L, Gutmann DH, Wong M : Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 63 : 444-453, 2008 https://doi.org/10.1002/ana.21331
- Zoncu R, Efeyan A, Sabatini DM : MTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12 : 21-35, 2011 https://doi.org/10.1038/nrm3025
피인용 문헌
- Astrocytes: Role and Functions in Brain Pathologies vol.10, 2019, https://doi.org/10.3389/fphar.2019.01114
- Mechanistic target of rapamycin (mTOR) implicated in plasticity of the reproductive axis during social status transitions vol.282, 2019, https://doi.org/10.1016/j.ygcen.2019.113209
- Brain somatic mutations in MTOR reveal translational dysregulations underlying intractable focal epilepsy vol.129, pp.10, 2019, https://doi.org/10.1172/jci127032
- Advances in genetic testing and optimization of clinical management in children and adults with epilepsy vol.20, pp.3, 2019, https://doi.org/10.1080/14737175.2020.1713101
- Novel therapeutic targets in epilepsy: oxidative stress and iron metabolism vol.46, pp.6, 2020, https://doi.org/10.1111/nan.12615
- Non-synaptic Cell-Autonomous Mechanisms Underlie Neuronal Hyperactivity in a Genetic Model of PIK3CA-Driven Intractable Epilepsy vol.14, 2021, https://doi.org/10.3389/fnmol.2021.772847
- Application of single cell genomics to focal epilepsies: A call to action vol.31, pp.4, 2019, https://doi.org/10.1111/bpa.12958